SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 571 filers reported holding SEAGEN INC in Q1 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,328,440,446 | +14.3% | 6,261,798 | +3.7% | 1.12% | +15.4% |
| Q2 2023 | $1,162,228,988 | +17.3% | 6,038,808 | +23.4% | 0.97% | +12.4% |
| Q1 2023 | $991,051,776 | +61.8% | 4,894,808 | +2.7% | 0.86% | +54.0% |
| Q4 2022 | $612,424,429 | -2.3% | 4,765,578 | +4.0% | 0.56% | -7.6% |
| Q3 2022 | $627,106,000 | -22.8% | 4,583,100 | -0.1% | 0.61% | -16.4% |
| Q2 2022 | $811,909,000 | +21.9% | 4,588,610 | -0.7% | 0.73% | +44.6% |
| Q1 2022 | $665,930,000 | -7.3% | 4,622,910 | -0.5% | 0.50% | +1.0% |
| Q4 2021 | $718,440,000 | -12.5% | 4,647,090 | -3.9% | 0.50% | -14.3% |
| Q3 2021 | $821,136,000 | +6.1% | 4,835,900 | -1.3% | 0.58% | +11.5% |
| Q2 2021 | $773,836,000 | +11.3% | 4,901,420 | -2.1% | 0.52% | +7.2% |
| Q1 2021 | $695,438,000 | -26.1% | 5,008,195 | -6.8% | 0.48% | -30.6% |
| Q4 2020 | $941,012,000 | – | 5,372,912 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |